STAMFORD, Conn., Nov. 04, 2023 (GLOBE NEWSWIRE) — Abbott Cooper PLLC is investigating Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL) (“Zentalis” or the “Company”) on behalf of the Company’s investors.
The investigation seeks to determine whether Zentalis’ board of directors has violated its fiduciary duty by instituting measures that impermissibly interfere with the ability of Zentalis stockholders to elect directors of their choosing.
Zentalis stockholders are encouraged to contact Abbott Cooper PLLC by calling (475) 333-0674, emailing ac@abbottlawyer.com or visiting our website at www.abbottlawyer.com for additional information about this investigation as well as their legal rights and options.
Abbott Cooper PLLC is dedicated to shareholders’ rights and empowering shareholders through strategic counsel and legal advocacy. For additional information about Abbott Cooper PLLC, please visit www.abbottlawyer.com.
CONTACT:
Abbott Cooper PLLC
Abbott Cooper
(475) 333-0674
www.abbottlawyer.com
Attorney advertising. Prior results do not guarantee a similar outcome.
- Encore Data Products Unveils Califone Soft Floor Rockers and Gaming Chairs for Ultimate Comfort and Support - June 3, 2025
- Avista enacts temporary change to power line operations for summer - June 3, 2025
- Pixalate’s May 2025 United States Publisher Rankings for Websites, Mobile & CTV Apps: ‘Fox News’, spotify.com, ‘Hulu’, ‘ESPN’, and ‘DirecTV’ Among Top-Ranked For Open Programmatic Ad Traffic Quality - June 3, 2025
